Jazz Pharmaceuticals (JAZZ) Inventory (2010 - 2026)
Jazz Pharmaceuticals' quarterly Inventory came in at $437.5 million in Q1 2026, down 11.22% year-on-year from $492.8 million in Q1 2025, and up 4.92% quarter-over-quarter from $417.0 million in Q4 2025.
Jazz Pharmaceuticals has reported Inventory for 17 years, with the latest figure at $437.5 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory fell 11.22% year-over-year to $437.5 million; the trailing twelve-month figure through Mar 2026 stood at $437.5 million (down 11.22% YoY), and the FY2025 full-year result was $417.0 million, down 13.21% from the prior year.
- Inventory for Q1 2026 stood at $437.5 million, up from $417.0 million in the prior quarter.
- The five-year high for Inventory was $985.5 million in Q1 2022, with the low at $417.0 million in Q4 2025.
- Average Inventory over 5 years is $606.2 million, with a median of $577.3 million recorded in 2024.
- Peak annual rise in Inventory reached 753.39% in 2022, while the deepest fall reached 36.01% in 2022.
- Tracing JAZZ's Inventory over 5 years: stood at $714.1 million in 2022, then declined by 16.39% to $597.0 million in 2023, then dropped by 19.53% to $480.4 million in 2024, then declined by 13.21% to $417.0 million in 2025, then grew by 4.92% to $437.5 million in 2026.
- The last three Inventory figures came in at $437.5 million (Q1 2026), $417.0 million (Q4 2025), and $483.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn | 437.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 437.50 Mn |
| Dec 31, 2025 | 417.00 Mn |
| Sep 30, 2025 | 483.11 Mn |
| Jun 30, 2025 | 504.99 Mn |
| Mar 31, 2025 | 492.78 Mn |
| Dec 31, 2024 | 480.45 Mn |
| Sep 30, 2024 | 539.30 Mn |
| Jun 30, 2024 | 542.56 Mn |
| Mar 31, 2024 | 577.32 Mn |
| Dec 31, 2023 | 597.04 Mn |
| Sep 30, 2023 | 611.83 Mn |
| Jun 30, 2023 | 657.21 Mn |
| Mar 31, 2023 | 674.78 Mn |
| Dec 31, 2022 | 714.06 Mn |
| Sep 30, 2022 | 728.07 Mn |
| Jun 30, 2022 | 861.71 Mn |
| Mar 31, 2022 | 985.45 Mn |
| Dec 31, 2021 | 1.07 Bn |
| Sep 30, 2021 | 1.14 Bn |
| Jun 30, 2021 | 1.25 Bn |
| Mar 31, 2021 | 115.48 Mn |
| Dec 31, 2020 | 95.40 Mn |
| Sep 30, 2020 | 91.40 Mn |
| Jun 30, 2020 | 92.53 Mn |
| Mar 31, 2020 | 85.61 Mn |
| Dec 31, 2019 | 78.61 Mn |
| Sep 30, 2019 | 71.11 Mn |
| Jun 30, 2019 | 69.00 Mn |
| Mar 31, 2019 | 60.71 Mn |
| Dec 31, 2018 | 52.96 Mn |
| Sep 30, 2018 | 43.44 Mn |
| Jun 30, 2018 | 46.16 Mn |
| Mar 31, 2018 | 46.38 Mn |
| Dec 31, 2017 | 43.25 Mn |
| Sep 30, 2017 | 41.34 Mn |
| Jun 30, 2017 | 39.66 Mn |
| Mar 31, 2017 | 37.65 Mn |
| Dec 31, 2016 | 34.05 Mn |
| Sep 30, 2016 | 32.35 Mn |
| Jun 30, 2016 | 33.29 Mn |
| Mar 31, 2016 | 25.37 Mn |
| Dec 31, 2015 | 19.45 Mn |
| Sep 30, 2015 | 30.02 Mn |
| Jun 30, 2015 | 30.78 Mn |
| Mar 31, 2015 | 30.69 Mn |
| Dec 31, 2014 | 30.04 Mn |
| Sep 30, 2014 | 37.61 Mn |
| Jun 30, 2014 | 33.10 Mn |
| Mar 31, 2014 | 36.99 Mn |
| Dec 31, 2013 | 28.67 Mn |
| Sep 30, 2013 | 24.87 Mn |
| Jun 30, 2013 | 28.13 Mn |
| Mar 31, 2013 | 22.83 Mn |
| Dec 31, 2012 | 26.53 Mn |
| Sep 30, 2012 | 30.30 Mn |
| Jun 30, 2012 | 48.36 Mn |
| Mar 31, 2012 | 16.99 Mn |
| Dec 31, 2011 | 3.91 Mn |
| Sep 30, 2011 | 4.30 Mn |
| Jun 30, 2011 | 4.74 Mn |
| Dec 31, 2010 | 5.05 Mn |